Advances in Urology / 2012 / Article / Tab 3

Clinical Study

Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer

Table 3

Planning parameters for all patients and according to prescription. CTV: clinical target volume; Gy: Gray; PTV: planning target volume; R40 and R60: percentage of the rectal volume receiving a dose of 40 and 60 Gy, respectively; Rmean: mean dose to the rectum, Bmax and Bmean: maximal and mean dose to the bladder.

All ( )74R72 ( )76R74 ( )78R76 ( )

CTV volume (cc)61 (22–180)86 (26–146)68 (28–112)53 (22–180)
Minimum CTV dose (Gy)73 (55–77)68 (55–70)72 (67–74)73 (68–77)
Median CTV dose (Gy)78 (72–83)76 (72–78)77 (72–82)79 (74–83)
PTV volume (cc)155 (48–347)250 (121–347)226 (100–289)123 (48–296)
Minimum PTV dose (Gy)69 (52–73)65 (52–68)67 (65–70)69 (64–73)
Median PTV dose (Gy)77 (70–82)74 (70–76)75 (72–80)78 (75–82)
R4071 (30–97)90 (88–90)87 (57–97)68 (30–94)
R6043 (22–90)64 (29–90)54 (26–69)40 (22–63)
Rmean51 (33–71)57 (39–65)54 (37–62)49 (33–71)
Bmax79 (72–82)78 (72–79)79 (76–82)79 (76–82)
Bmean43 (13–72)49 (19–68)58 (16–65)40 (13–72)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.